• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » U.K. clinical trials database first major output for Cell Therapy Catapult

U.K. clinical trials database first major output for Cell Therapy Catapult

January 18, 2013
CenterWatch Staff

The Cell Therapy Catapult, focused on the development of the U.K. cell therapy industry to increase the nation's health and wealth, has published its database of ongoing clinical trials in this area in the U.K.

The database details 21 studies and will be used by the organization to identify potential programs for development or partnership, as well to provide a key indication of progress in the U.K. cell therapy industry.

The database will be updated regularly and input from the cell therapy community is welcome to ensure it remains comprehensive and accurate.

Key findings from the Cell Therapy Catapult U.K. Clinical Trials Database include:

  • Roughly 75% of U.K. clinical trials are sponsored by a research institution
  • Diverse cell types are being investigated, although bone marrow cells predominate
  • Transplant/oncology indications dominate, although there is also significant activity in cardiovascular and neurological indications
  • The majority of cell therapies are in phase I/ll or II trials, highlighting the translational gap the Cell Therapy Catapult is looking to address.

The database includes all current academic and commercial trials in the U.K., regardless of the nationality of the sponsor, and covers those involving cells as therapeutic agents (excluding established stem cell transplants and gene therapy delivery systems).

Later this year, the Cell Therapy Catapult plans to publish a database of cell therapies likely to enter clinical development in the next few years.

“The U.K. Clinical Trials Database is one of our early outputs, and an important part of our engagement with the community, whose input and comments we welcome,” said Keith Thompson, CEO of the Cell Therapy Catapult. “It's encouraging to see the quality of the early- stage work ongoing in the U.K., although the need to convert this into late-stage and commercial products is clear. The Cell Therapy Catapult is working to address this translational gap, and we will be using the database to help monitor our progress.”

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing